KR960701010A - 사람 면역결핍 바이러스(HIV) 역전사효소의 억제제(Inhibitors of HIV reverse transcriptase) - Google Patents
사람 면역결핍 바이러스(HIV) 역전사효소의 억제제(Inhibitors of HIV reverse transcriptase)Info
- Publication number
- KR960701010A KR960701010A KR1019950703549A KR19950703549A KR960701010A KR 960701010 A KR960701010 A KR 960701010A KR 1019950703549 A KR1019950703549 A KR 1019950703549A KR 19950703549 A KR19950703549 A KR 19950703549A KR 960701010 A KR960701010 A KR 960701010A
- Authority
- KR
- South Korea
- Prior art keywords
- inhibitors
- reverse transcriptase
- hiv reverse
- hiv
- transcriptase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/12—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2192593A | 1993-02-24 | 1993-02-24 | |
| PCT/US1994/001694 WO1994019321A1 (en) | 1993-02-24 | 1994-02-15 | Inhibitors of hiv reverse transcriptase |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR960701010A true KR960701010A (ko) | 1996-02-24 |
Family
ID=21806886
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019950703549A KR960701010A (ko) | 1993-02-24 | 1995-08-23 | 사람 면역결핍 바이러스(HIV) 역전사효소의 억제제(Inhibitors of HIV reverse transcriptase) |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0686148A4 (bg) |
| JP (1) | JPH08507067A (bg) |
| KR (1) | KR960701010A (bg) |
| CN (1) | CN1119856A (bg) |
| AU (1) | AU6254294A (bg) |
| BG (1) | BG62089B1 (bg) |
| BR (1) | BR9405737A (bg) |
| CA (1) | CA2156420A1 (bg) |
| FI (1) | FI953954A0 (bg) |
| HU (1) | HUT74614A (bg) |
| NO (1) | NO953308L (bg) |
| PL (1) | PL175788B1 (bg) |
| WO (1) | WO1994019321A1 (bg) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6989263B1 (en) * | 1994-09-23 | 2006-01-24 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Method for identifying and using compounds that inactivate HIV-1 and other retroviruses by attacking highly conserved zinc fingers in the viral nucleocapsid protein |
| US5811425A (en) * | 1997-03-04 | 1998-09-22 | Abbott Laboratories | Heterocyclic compounds as COX-2 inhibitors |
| GB9902455D0 (en) * | 1999-02-05 | 1999-03-24 | Zeneca Ltd | Chemical compounds |
| AU7962200A (en) * | 1999-10-29 | 2001-05-14 | Wakunaga Pharmaceutical Co., Ltd | Novel indole derivatives and drugs containing the same as the active ingredient |
| EP1390029B1 (en) * | 2001-04-11 | 2009-12-16 | Idenix (Cayman) Limited | Phenylindoles for the treatment of hiv |
| SE0201635D0 (sv) * | 2002-05-30 | 2002-05-30 | Astrazeneca Ab | Novel compounds |
| TW200307542A (en) | 2002-05-30 | 2003-12-16 | Astrazeneca Ab | Novel compounds |
| SE0202241D0 (sv) | 2002-07-17 | 2002-07-17 | Astrazeneca Ab | Novel Compounds |
| US7365090B2 (en) | 2002-08-07 | 2008-04-29 | Idenix Pharmaceuticals, Inc. | Substituted phenylindoles for the treatment of HIV |
| AU2003261415C1 (en) * | 2002-08-09 | 2010-01-14 | Merck Sharp & Dohme Corp. | Tyrosine kinase inhibitors |
| WO2004014300A2 (en) * | 2002-08-09 | 2004-02-19 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
| US7642277B2 (en) | 2002-12-04 | 2010-01-05 | Boehringer Ingelheim International Gmbh | Non-nucleoside reverse transcriptase inhibitors |
| SE0301569D0 (sv) | 2003-05-27 | 2003-05-27 | Astrazeneca Ab | Novel compounds |
| SE0302232D0 (sv) | 2003-08-18 | 2003-08-18 | Astrazeneca Ab | Novel Compounds |
| CN100439367C (zh) * | 2003-12-11 | 2008-12-03 | 安万特药物公司 | 作为酪蛋白激酶Iε抑制剂的取代的1H-吡咯并[3,2-b、3,2-c和2,3-c]吡啶-2-甲酰胺以及相关类似物 |
| CA2577511A1 (en) * | 2004-08-19 | 2006-03-02 | Aventis Pharmaceuticals Inc. | 3-arylthioindole-2-carboxamide derivatives and analogs thereof as inhibitors of casein kinase ie |
| NZ554232A (en) | 2004-09-17 | 2010-09-30 | Idenix Pharmaceuticals Inc | Phosphoindoles as HIV inhibitors |
| GB0500604D0 (en) | 2005-01-13 | 2005-02-16 | Astrazeneca Ab | Novel process |
| CN102558021A (zh) | 2006-05-26 | 2012-07-11 | 阿斯利康(瑞典)有限公司 | 联芳基或芳基-杂芳基取代的吲哚类化合物 |
| EP2078029B1 (en) * | 2006-09-29 | 2014-05-14 | IDENIX Pharmaceuticals, Inc. | Enantiomerically pure phosphoindole as hiv inhibitor |
| BRPI0908851A2 (pt) * | 2008-02-22 | 2017-05-30 | Irm Llc | compostos e composições como moduladores da atividades de gpr119 |
| CA2797281A1 (en) * | 2010-05-06 | 2011-11-10 | Merck Sharp & Dohme Corp. | Aza-indole derivatives useful as modulators of faah |
| CN106892854B (zh) * | 2015-12-21 | 2019-04-30 | 中国海洋大学 | 一种吲哚生物碱类化合物及其制备方法和用途 |
| CN107151223B (zh) * | 2016-03-10 | 2020-03-31 | 中国医学科学院药物研究所 | 一类n-烷基吲哚类化合物在制备抗流感病毒药物中的用途 |
| CN106995400B (zh) * | 2017-04-10 | 2019-08-06 | 湘潭大学 | 一种化合物及其盐及其合成方法 |
| CN112375027B (zh) * | 2020-12-07 | 2023-03-31 | 中国药科大学 | 吲哚磺酰胺类衍生物及其医药用途 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1935671C3 (de) * | 1968-04-26 | 1975-01-09 | Sumitomo Chemical Co | 2-Aminomethylindole und ihre Salze |
| US4255442A (en) * | 1977-08-29 | 1981-03-10 | Schering Corporation | 2-[(Methylsulfinyl)]-3-phenylindoles |
| IT1098266B (it) * | 1977-08-29 | 1985-09-07 | Scherico Ltd | 2-sostituti-3-fenilindoli,procedimento per la loro preparazione e per il loro impiego come immunosoppresori |
| NZ222878A (en) * | 1986-12-17 | 1991-02-26 | Merck Frosst Canada Inc | 3-hetero-substituted-n-benzyl-indole derivatives, and pharmaceutical compositions |
| CA1338012C (en) * | 1987-04-27 | 1996-01-30 | John Michael Mccall | Pharmaceutically active amines |
| US5268389A (en) * | 1989-10-16 | 1993-12-07 | Uniroyal Chemical Company, Inc. | Thiocarboxylate ester compounds compositions containing the same |
| ES2093090T3 (es) * | 1989-12-28 | 1996-12-16 | Upjohn Co | Compuestos sustituidos diaromaticos anti-sida. |
| WO1993005020A1 (en) * | 1991-09-06 | 1993-03-18 | Merck & Co., Inc. | Indoles as inhibitors of hiv reverse transcriptase |
-
1994
- 1994-02-15 CA CA002156420A patent/CA2156420A1/en not_active Abandoned
- 1994-02-15 EP EP94909663A patent/EP0686148A4/en not_active Withdrawn
- 1994-02-15 AU AU62542/94A patent/AU6254294A/en not_active Abandoned
- 1994-02-15 BR BR9405737A patent/BR9405737A/pt not_active Application Discontinuation
- 1994-02-15 PL PL94310410A patent/PL175788B1/pl unknown
- 1994-02-15 HU HU9502468A patent/HUT74614A/hu unknown
- 1994-02-15 CN CN94191586A patent/CN1119856A/zh active Pending
- 1994-02-15 JP JP6519119A patent/JPH08507067A/ja active Pending
- 1994-02-15 WO PCT/US1994/001694 patent/WO1994019321A1/en not_active Application Discontinuation
-
1995
- 1995-08-23 NO NO953308A patent/NO953308L/no unknown
- 1995-08-23 FI FI953954A patent/FI953954A0/fi not_active Application Discontinuation
- 1995-08-23 BG BG99879A patent/BG62089B1/bg unknown
- 1995-08-23 KR KR1019950703549A patent/KR960701010A/ko not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0686148A4 (en) | 1996-02-07 |
| JPH08507067A (ja) | 1996-07-30 |
| NO953308L (no) | 1995-10-24 |
| EP0686148A1 (en) | 1995-12-13 |
| HUT74614A (en) | 1997-01-28 |
| AU6254294A (en) | 1994-09-14 |
| PL175788B1 (pl) | 1999-02-26 |
| NO953308D0 (no) | 1995-08-23 |
| BG62089B1 (bg) | 1999-02-26 |
| HU9502468D0 (en) | 1995-10-30 |
| PL310410A1 (en) | 1995-12-11 |
| CN1119856A (zh) | 1996-04-03 |
| FI953954A (fi) | 1995-08-23 |
| WO1994019321A1 (en) | 1994-09-01 |
| BG99879A (bg) | 1996-02-28 |
| CA2156420A1 (en) | 1994-09-01 |
| FI953954A0 (fi) | 1995-08-23 |
| BR9405737A (pt) | 1995-12-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR960701010A (ko) | 사람 면역결핍 바이러스(HIV) 역전사효소의 억제제(Inhibitors of HIV reverse transcriptase) | |
| AU641769B2 (en) | Inhibitors of HIV reverse transcriptase | |
| AU2216292A (en) | Inhibitors of hiv reverse transcriptase | |
| PT885887E (pt) | Inibidores de sulfonamida de aspartil-protease de hiv | |
| ATE362918T1 (de) | Hiv protease inhibitoren | |
| AU1046895A (en) | New quinazolines as inhibitors of hiv reverse transcriptase | |
| AU8693491A (en) | Synergism of hiv reverse transcriptase inhibitors | |
| FI935644A (fi) | Retrovirusten proteaasi-inhibiittoreita | |
| FI945199A0 (fi) | HIV-käänteiskopioijaentsyymin uudet kinatsoliini-inhibiittorit | |
| EP0462808A3 (en) | Inhibitors of hiv reverse transcriptase | |
| GB9308781D0 (en) | Inhibitors of hiv reverse transcriptase | |
| ZA914653B (en) | Inhibitors of hiv reverse transcriptase | |
| ZA914654B (en) | Inhibitors of hiv reverse transcriptase | |
| ZA926708B (en) | Inhibitors of hiv reverse transcriptase | |
| NO953272L (no) | Kombinasjoner av retrovirale inhibitorer | |
| NO920025L (no) | Synergime av hiv-reverstranskriptaseinhibitorer | |
| ZA935724B (en) | Benzoxazinones as inhibitors of HIV reverse transcriptase | |
| NO920023L (no) | Hiv-proteaseinhibitorer | |
| ZA933179B (en) | New quinazolines as inhibitors of hiv reverse transcriptase. | |
| ZA918659B (en) | Synergism of hiv reverse transcriptase inhibitors | |
| GB9520721D0 (en) | HIV reverse transcriptase inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |